Sanofi
Merck sells Merial share, but retains animal health option
September 21, 2009Sales and Marketing Merck, Merial, Sanofi, animal health
Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …
Sanofi boosted by Multaq vote of approval
March 19, 2009Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US
An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …
Viehbacher sets out vision for diversified Sanofi-Aventis
February 11, 2009Sales and Marketing Sanofi
Sanofi-Aventis's new chief executive Chris Viehbacher has presented his vision to renew the company, which will include greater investment in …
Sanofi cleared to buy Zentiva
February 11, 2009Sales and Marketing Sanofi, generics
The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …
Sanofi appoints new finance head
December 11, 2008Sales and Marketing Sanofi, restructure
Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …
Latest news from Datamonitor
November 3, 2008Sales and Marketing Acomplia, Sanofi
Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …
Sanofi seals Zentiva deal with improved offer
September 23, 2008Sales and Marketing MA, Sanofi, generics
Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …
Viehbacher leaves GSK for Sanofi
September 10, 2008Sales and Marketing GSK, Sanofi
Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …
Latest content
Five Facts about cardiovascular disease
